Advertisement
Screener

Citius Pharmaceuticals, Inc. (CTXR) Long-term Purchase Commitment, Amount

2.8 / 5 stars · 68/120 Roast Me

Citius Pharmaceuticals, Inc. Long-term Purchase Commitment, Amount

Citius Pharmaceuticals, Inc. (CTXR) had Long-term Purchase Commitment, Amount of $5.40 million as of 2026-09-30, per its 10-K filed 2024-12-27.

Financial Statements › Notes › Commitment and Contingencies

us-gaap:LongTermPurchaseCommitmentAmount · last filed 2025-12-23

  • 2026-09-30: Long-term Purchase Commitment, Amount $5.40M.
  • 2025-09-30: Long-term Purchase Commitment, Amount $8.50M; Long-term Purchase Commitment, Amount as first filed $11.90M.
Period endLong-term Purchase Commitment, AmountLong-term Purchase Commitment, Amount as first filed
2026-09-30$5.40M
10-K · filed 2024-12-27
2025-09-30$8.50M
10-K · filed 2025-12-23
$11.90M
10-K · filed 2024-12-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36